|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
36
|
|
pubmed:dateCreated |
2010-9-2
|
|
pubmed:abstractText |
We report in this Communication a facile, two-step surface modification strategy to achieve manganese oxide nanoparticles with prominent MRI T1 contrast. In a U87MG glioblastoma xenograft model, we confirmed that the particles can accumulate efficiently in tumor area to induce effective T1 signal alteration.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1364-548X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
28
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6684-6
|
|
pubmed:meshHeading |
pubmed-meshheading:20730157-Animals,
pubmed-meshheading:20730157-Contrast Media,
pubmed-meshheading:20730157-Copper Radioisotopes,
pubmed-meshheading:20730157-Humans,
pubmed-meshheading:20730157-Magnetic Resonance Imaging,
pubmed-meshheading:20730157-Manganese Compounds,
pubmed-meshheading:20730157-Metal Nanoparticles,
pubmed-meshheading:20730157-Mice,
pubmed-meshheading:20730157-Neoplasms, Experimental,
pubmed-meshheading:20730157-Oxides,
pubmed-meshheading:20730157-Positron-Emission Tomography,
pubmed-meshheading:20730157-Serum Albumin,
pubmed-meshheading:20730157-Transplantation, Heterologous
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
|
|
pubmed:affiliation |
Department of Radiology and Bio-X Program, Stanford University, 1201 Welch Road P087, Stanford, CA 94305, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Intramural
|
